Bank of America on Pace for Largest Percent Decrease Since March 2023 — Data Talk
Bank of America Corp (BAC) is currently at $34.52, down $1.43 or 3.98%
--Would be lowest close since March 1, 2024, when it closed at $34.35
--On pace for largest percent decrease since March 13, 2023, when it fell 5.81%
--Currently down four of the past five days
--Down 8.97% month-to-date
--Up 2.52% year-to-date
--Down 37.12% from its all-time closing high of $54.90 on Nov. 20, 2006
--Up 12.96% from 52 weeks ago (April 18, 2023), when it closed at $30.56
--Down 8.97% from its 52-week closing high of $37.92 on March 28, 2024
--Up 37.15% from its 52-week closing low of $25.17 on Oct. 27, 2023
--Traded as low as $34.43; lowest intraday level since March 4, 2024, when it hit $34.25
--Down 4.23% at today's intraday low; largest intraday percent decrease since Feb. 16, 2024, when it fell as much as 4.64%
--Third worst performer in the S&P 500 today
--Second most active stock in the S&P 500 today
All data as of 10:06:28 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 16, 2024 10:23 ET (14:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track